EcoDrugPlus

Protein Kinase C Theta Type

Ensembl ID : ENSOKIG00005031379
Gene Symbol: LOC109910344
3 Cross references
201 Possible Orthologues:

Protein Kinase C Theta Type-Like

Ensembl ID : ENSOKIG00005003314
Gene Symbol: LOC109910350
3 Cross references
202 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSOKIG00005006443
Gene Symbol: PRKCZ
1 Cross references
194 Possible Orthologues:

Protein Kinase C Zeta Type

Ensembl ID : ENSOKIG00005034681
Gene Symbol: LOC109869631
3 Cross references
195 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSOKIG00005042993
Gene Symbol: PRKCHA
1 Cross references
218 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOKIG00005017209
Gene Symbol: PRKD1
3 Cross references
195 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOKIG00005013388
Gene Symbol: PRKD1
1 Cross references
195 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOKIG00005033931
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOKIG00005003135
Gene Symbol: PRKD3
3 Cross references
195 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOKIG00005037853
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSOKIG00005027262
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSOKIG00005025273
Gene Symbol: PPP3CA
3 Cross references
228 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).